Skip to content

Lead Pharma Medicine B.V.

Closed bankruptcy
5 financial reports
KvK
09172969
Establishment
Oss, Noord-Brabant
Sector
Not known
Bankruptcy number
F.01/25/159
Judgment
June 17, 2025
Insolvency practitioner
mr. D.P. Schalken, BG.Legal

Summary

On June 17, 2025, the Rechtbank Oost-Brabant declared Lead Pharma Medicine B.V. bankrupt (insolvency number F.01/25/159). The proceedings ended on September 29, 2026. It is a BV from Oss (Noord-Brabant). Its KvK number is 09172969. mr. D.P. Schalken (BG.Legal) has been appointed insolvency practitioner. mr. S.C.E.F. Moulen Janssen has been appointed supervisory judge. There are 4 public reports; the latest is report 4 of April 8, 2026. In addition, there are 5 financial reports; the latest is financial report of August 11, 2026. Estate assets according to financial report 4: €315,857.06. Key figures according to report 4: unsecured claims €680,175.99, creditors 21 en preferential claims €580,086.57. Status according to report 4: completed: causes of the bankruptcy; no indications according to the insolvency practitioner: legal proceedings.

Noord-Brabant recorded 481 bankruptcies in the past twelve months. Of these, 18 came from the municipality of Oss.

Unsecured claims according to report 4 of April 8, 2026: €680,175.99 (in report 3 of January 14, 2026: €669,975.99).

Hours spent according to report 4 of April 8, 2026: 221 h 12 min (in report 3 of January 14, 2026: 191 h 48 min).

In report 4, the reported position changed as follows: actio pauliana mentioned for the first time (mentioned), bookkeeping obligation from under investigation to mentioned, director liability from under investigation to mentioned, lawfulness investigation from under investigation to mentioned, and causes of the bankruptcy from mentioned to completed.

Employees according to report 4 of April 8, 2026: 18.

The procedure ended on September 29, 2026. The termination notice and any final reports describe how the case was concluded; termination does not automatically mean that all creditors have been paid.

New since report 4

8 changes

Public report 4 of April 8, 2026, compared with report 3 of January 14, 2026

Compare report 3 and report 4

New

Changed

  • Unsecured claims

    €669,975.99 €680,175.99

  • Hours spent

    191 h 48 min 221 h 12 min

  • Creditors

    20 21

Completed

Estate assets Fin. report 4
€315,857.06, history of Estate assets

+€209.41 since financial report 3

Unsecured claims Report 4
€680,175.99, history of Unsecured claims

+€10,200 since report 3

Preferential Report 4
€580,086.57, history of Preferential

unchanged

Creditors Report 4
21, history of Creditors

+1 since report 3

Employees Report 4
18, history of Employees

unchanged

Further case information

Status

Rent and lease
Mentioned Rent and lease
Causes of the bankruptcy
Completed Causes of the bankruptcy
Tot heden is de curator het volgende gebleken uit gesprekken met het bestuur en betrokkenen, maar dit vormt geen conclusie. Lead Pharma Medicine B.V. exploiteert een farmaceutisch onderzoeks- en ontw ikkelbedrijf. Daartoe verricht zij onderzoek naar nieuw e medicijnen ter genezing van kanker en auto-immuunziekten. Medicijnonderzoek is een langdurig en kostbaar traject. Van een idee naar verkoop du
Staff
Mentioned Staff
Sale of assets
Mentioned Sale of assets
Collection of receivables
Mentioned Collection of receivables
Security rights
Mentioned Security rights
Bookkeeping obligation
Mentioned Bookkeeping obligation
Filing of annual accounts
Completed Filing of annual accounts
Director liability
Mentioned Director liability
Actio pauliana
Mentioned Actio pauliana
Legal proceedings
No indications Legal proceedings
Lawfulness investigation
Mentioned Lawfulness investigation

Recent timeline

  1. Publication in the insolvency register

    Opheffing faillissement wegens gebrek aan baten op 29 september 2026

  2. Proceedings ended for lack of assets

  3. Public financial report of August 11, 2026 published

  4. Publication in the insolvency register

    Vereenvoudigde afwikkeling van het faillissement

  5. Financial data changed in report 4

Key documents

  • Opheffing faillissement wegens gebrek aan baten op 29 september 2026

    09-30-2026 1 p. Central Insolvency Register

    View
  • Financieel verslag 04-08-2026

    08-11-2026 10 p. Rechtspraak

    View
  • Vereenvoudigde afwikkeling van het faillissement

    05-13-2026 1 p. Central Insolvency Register

    View
  • Verslag: 08-04-2026

    04-08-2026 17 p. Rechtspraak

    View

What you want to know about Lead Pharma Medicine B.V.

Who is the bankruptcy trustee of Lead Pharma Medicine B.V.?

The Rechtbank Oost-Brabant has appointed mr. D.P. Schalken of BG.Legal as bankruptcy trustee. For questions about the bankruptcy, please contact the bankruptcy trustee.

On what date did Lead Pharma Medicine B.V. go bankrupt?

Lead Pharma Medicine B.V. was declared bankrupt by the Rechtbank Oost-Brabant on June 17, 2025. The case has insolvency number F.01/25/159.

How does the bankruptcy of Lead Pharma Medicine B.V. affect creditors?

In a bankruptcy the company may no longer dispose of its assets itself. The insolvency practitioner manages and sells the assets and distributes the proceeds among the creditors according to the statutory ranking. Whether and how much ordinary creditors receive usually only becomes clear at the end.

Are there public reports on the bankruptcy?

Yes, there are 4 public reports; the most recent is from April 8, 2026. You can find them under Reports in this case.

Company details

Legal form
BV

Sources

Not known: sbi code, founded, kvk registration, trade names

Addresses

  • Correspondence address Trading address
    Kloosterstraat 9 5349 AB Oss
    • Built in 2004
    • industriefunctie
    • 87 m²
  • Business address Trading address
    Kloosterstraat 9RK 5349 AB Oss
    • Built in 2004
    • industriefunctie
    • 87 m²

Affiliated companies